Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
Recruiting · NCT07174427 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, sarcoma, synovial sarcoma | Recruiting | Phase 3 | 2026-09-28 | NCT07174427 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Takara Bio Inc. | 5 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kyusyu University Hospital | Fukuoka | Japan | 1 |
| National Cancer Center Hospital East | Kashiwa | Japan | 7 |
| Osaka International Cancer Institute | Osaka | Japan | 16 |